James McCormack

James McCormack is a Professor with the Faculty of Pharmaceutical Sciences at the University of British Columbia in Vancouver. He received his undergraduate pharmacy degree at the University of British Columbia in 1982 and completed a hospital pharmacy residency program at Lion’s Gate Hospital in North Vancouver in 1984. He received his doctorate in pharmacy (Pharm.D.) in 1986 from the Medical University of South Carolina in Charleston, South Carolina.

His main area of research/scholarly activity is in the area of providing physicians and pharmacists with up to date, evidence based, practical information in the area of rational drug therapy.  James has had extensive experience, both locally and internationally, talking to health professionals and consumers about the rational use of medication and has presented over 250 seminars on drug therapy over the last 15 years, now available in podcast from Apple iTunes. Much of this work is done in conjunction with the Therapeutics Initiative www.ti.ubc.ca at the University of British Columbia. In addition, he has written numerous articles in the medical literature on the area of rational drug therapy and has been an editor for two internationally recognized textbooks on appropriate/rational drug therapy.

Download a new hi-res photo of James McCormack

Commentaries by Dr. James McCormack: 

Maybe the diet you are on right now is actually a pretty good one
Just how many servings of fruits and vegetables should we eat a day?
 // Combien de portions de fruits et de légumes devrions nous manger tous les jours?
Sure fire tricks to get the most out of your vitamin supplements // Les astuces les plus sûres pour tirer le maximum des suppléments vitaminiques
New cholesterol treatment guidelines reassess statin drug use
Why heart health is not just a numbers game // La santé du cœur, ce n’est pas qu’une question de taux
Getting the right dose // La bonne dose

 

SaveSave

SaveSave

Print Friendly, PDF & Email

This work is licensed under a Creative Commons Attribution 4.0 International License.